Citations

Mayo Clinic

Showing 10 of 108376 citations.

Feasibility of Symptom Burden Assessments and Early Palliative Care Integration in an Adolescent and Young Adult Leukemia Clinic
Monick, Sarah, Hanson, Collin, Hoehn, K. Sarah , Henderson, Tara O. , Daugherty, Christopher K. , Wang, Amy , Monick, Sarah E, Hlubocky, Fay J. , Stock, Wendy , DuVall, Adam , McNeer, Jennifer L.

Journal of Adolescent and Young Adult Oncology | October 22, 2025 | Volume: 15 | Issue: 5 | Pages: 378-383

10.1177/21565333251389438 | PMID 41122915 Get It

Adolescents and young adults (AYA; ages 15–39) with acute leukemia have significant unmet supportive care needs. This pilot study integrated same-day palliative care (PC) into an AYA leukemia clinic, measuring symptom burden (SB) with validated symptom assessment tools at baseline, 3, and 6 months. Among 31 patients, moderate-severe symptoms included tiredness, anxiety, and poor appetite. AYAs experienced high SB and psychological distress, regardless of care phase or sociodemographics. With PC integration, tiredness and depression improved significantly; no symptoms worsened. Half of the PC visits led to management changes. Early integration of symptom-focused PC was feasible, value-adding, and well-received by patients.
Keeping the FAITH!: Psychosocial Factors and Healthy Lifestyle Among African-Americans During the COVID-19 Pandemic
McCoy, Carrie R. , Burgess, Ashya, Johnson, Matthew P. , Jones, Clarence F., Richard, Monisha, Erickson, Jamia, White, Richard O. , Weis, Jennifer A., Abbenyi, Adeline, Jones, Clarence , White, Richard O , Weis, Jennifer, Brockman, Tabetha A , Brewer, LaPrincess C , Sia, Irene G. , Wieland, Mark L. , Brockman, Tabetha A. , Doubeni, Chyke A. , Brewer, LaPrincess C.

Health Promotion Practice | October 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15248399251370692 | PMID 41122917 Get It

The COVID-19 pandemic caused unprecedented disruption of social networks and negatively impacted social determinants of health (SDoH, e.g., economic stability, mental health, health care access) among African Americans. The FAITH! (Fostering African-American Improvement in Total Health!) Program, an academic-community partnership with African American churches, pivoted to pandemic-related impacts on health behaviors of African Americans. This exploratory, cross-sectional study examined associations between multilevel factors influencing difficulty maintaining a healthy lifestyle during the early pandemic phase, including mental/emotional health and COVID-19 hardships (e.g., job/food/housing insecurity, paying utilities). An online survey was distributed via FAITH!-affiliated churches and social media. Logistic regression (odds ratios [ORs], adjusted for age/gender) and associated 95% confidence intervals [CIs]) examined associations between difficulty maintaining a healthy lifestyle and multilevel factors. Greater than half of respondents reported difficulty maintaining a healthy lifestyle (N = 169, 54% [91/169]). Adjusted odds of having difficulty maintaining a healthy lifestyle were greater for those reporting mental/emotional health issues (high-stress OR 4.0; 95% CI [1.9,8.9], p < .001); occasional symptoms of depression (OR 3.7; 95% CI [01.9,7.7]; p < .001); anger (OR 2.5; 95% CI [1.2,5.4]; p = .044), and anxiety (OR 2.8; 95% CI [1.4,6.0]; p = .008)). COVID-19 hardships of job insecurity (OR 1.4.; 95% CI [0.7, 2,8]; p = .015), difficulty paying rent (OR 4.4; 95% CI [2.1,9.9]; p < .001) or difficulty paying for food/utilities (OR 5.4; 95% CI [2.6,11.7]; p < .001) were associated with difficulty maintaining a healthy lifestyle. Our study revealed the negative impact of mental/emotional health and COVID-19 hardships on maintaining a healthy lifestyle among African Americans. This could inform SDoH-focused lifestyle interventions during future public health crises.
Commentary: HALP score and coronary bifurcation percutaneous coronary interventions: a promising prognostic tool
Abdelnabi, Mahmoud , Ibrahim, Ramzi , Ibrahim, Ramzi , Lee, Kwan

Acta Cardiologica | October 22, 2025 | Volume: 81 | Issue: 6 | Pages: 790-792

10.1080/00015385.2025.2576420 | PMID 41122773 Get It

Clinical and Metabolic Benefits of Efruxifermin in MASH: A GRADE-Assessed Meta-Analysis of Randomized Controlled Trials.
Abbas, Muhammad Sharjeel , Sohail, Fatima , Tariq, Hira , Pusa, Mounika, Ahmed, Muhammad , Ahmed, Musab Riyan, Shafi, N. , Hameed, Tayyaba, Shoukat, Shan e Ali, Ali, Basit, Ahmed, Muhammad , Abbas, Muhammad Sharjeel , Ahmed, Musab Riyan, Hameed, Tayyaba, Shoukat, Shan e Ali

No container title available | October 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.176112039.98341908/v1 Get It

A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry
Oak, Jean , Furtado, Felipe Magalhaes, Devitt, Katherine , Fromm, Jonathan R. , Qiu, Lianqun , Illingworth, Andrea , Cardinali, Jolene, Devitt, Katherine A , Qiu, Lianqun , Horna, Pedro , Kern, Wolfgang , Al-Attar, A , Shi, Min

Cytometry Part B: Clinical Cytometry | October 22, 2025 | Volume: 108 | Issue: 6 | Pages: 430-447

10.1002/cyto.b.22258 | PMID 41122063 Get It

Abstract The diagnosis of T‐cell neoplasms remains one of the most challenging areas in hematopathology due to the immunophenotypic heterogeneity and subtle aberrancies often present in these entities. This “Best Practice” manuscript provides a practical framework for laboratories to design, validate, and interpret immunophenotyping studies of immature and mature T‐cell neoplasms. We outline the utility of key antigens in the screening and classification of T‐cell lymphomas/leukemia including TRBC1 and TRBC2. Analytical strategies using the “difference from normal” method and template‐based gating are discussed, along with validation considerations aligned with CLSI H62 guidelines. By integrating these principles into laboratory workflows, this manuscript aims to standardize and improve the assessment of T‐cell neoplasms across diverse clinical settings.
Emergency department-initiated palliative care screening among older adults: a systematic review and meta-analysis protocol
Lin, Dimitri E , Mowbray, Fabrice , Isaacs, E. D., Markwalter, Daniel , Hay, Alison , Manfredi, Rita A. , Westlake, Erica , Bowman, Jason , Rebollo-Lee, Naomi, Gacioch, Brian, Brooten, Justin K. , Pajka, Sarah E. , Selman, Katie, Bain, Paul , Liu, Shan W. , Ouchi, Kei , Markwalter, Daniel , Ginsburg, Alexander D, Bain, Paul , Mowbray, Fabrice , Lin, Dimitri E , Gunaga, Satheesh , Isaacs, Eric D, George, Naomi R. , Akhter, Murtaza , Ginsburg, Alexander , Selman, Katherine , Davis, Joshua J.

BMJ Open | October 22, 2025 | Volume: 15 | Issue: 10 | Pages: e095894

10.1136/bmjopen-2024-095894 | PMID 41125269 Get It

Introduction The rapidly growing population of older adults (individuals aged 65 years and older) presents a new set of challenges for healthcare providers in the emergency department (ED), given the prevalence of severe and life-threatening conditions among this group, such as chronic cancer, Alzheimer’s disease/dementia and congestive heart failure. ED encounters often represent a critical point in an older patient’s trajectory of care and can thus be an important opportunity for various interventions such as palliative care consultation. Therefore, identifying those who will benefit most from palliative care is of high importance, especially in determining the course of future treatment. Thus, we aim to conduct a systematic review assessing the efficacy of palliative care screening in the ED by assessing inpatient length of stay as the primary outcome and quality of life, percentage of hospitalisation and cost of care as secondary outcomes. Methods This study will use Ovid MEDLINE, Embase, EBSCO CINAHL, Web of Science and Cochrane as databases. The study population comprises adults aged 60 years and older, with no focus on any specific clinical specialty or disease. Patients who have not received palliative care screening will serve as the comparator. Only studies with an applicable comparator will be considered. Studies published from 1 January 2000 to 1 July 2025 will be included. All articles will be reviewed independently and in duplicate, and every author will participate in the review, data abstraction and conflict resolution process. Ethics and dissemination Ethical approval is not required as it is a protocol for a systematic review. Findings will be disseminated through peer-reviewed publications and conference presentations. PROSPERO registration number CRD42024562389.
AAPM task group report 210: Conventional linear accelerator acceptance testing
Pérez-Andújar, A, Narayanasamy, Ganesh, Huang, Ellen , Li, Hua , Morrow, A, Rangaraj, D, Schupp, Nicholas, Yaddanapudi, Sridhar , Yan, Guanghua, Yang, Ching‐Chong Jack, Yaddanapudi, Sridhar , Holmes, Todd, Yan, Guanghua

Medical Physics | October 22, 2025 | Volume: 52 | Issue: 11 | Pages: No page available

10.1002/mp.70047 Get It

Abstract Increased demand to make medical linear accelerator acceptance testing procedures (ATP) more efficient exists while the technology being evaluated for clinical use has become increasingly complex. The most recent American Association of Physicists in Medicine (AAPM) task group giving guidelines to medical physicists on ATP was Task Group report 45, published in 1994. Several new technologies, enhanced machine performance, and possible future changes to ATP since that time require updated guidance from the AAPM. The goal of this task group is to empower the medical physicist to be meaningfully involved with the design and execution of comprehensive and effective linear accelerator ATP beginning with the purchasing contract negotiation to the contractual handover of the linear accelerator to the department for clinical use. Additionally, we discussed aspects related to beam matching, ATP at the time of replacing major linear accelerator's components as well as what we perceive as the future of the ATP process given the trends of standardizing linear accelerators.
Who Shapes the Future of Health Communication? Networks, Silos, and New Imperatives in the Digital Age
Britt, Rebecca K. , Franco, Courtny L. , Sams, Amanda, Ginwal, Priyanka , Obregón, Rafael , Ratzan, Scott C. , Ivic, Rebecca K , Franco, Courtny, Rubinelli, Sara , Sams, Amanda

Journal of Health Communication | October 22, 2025 | Volume: 30 | Issue: 10-12 | Pages: 522-527

10.1080/10810730.2025.2574675 | PMID 41121593 Get It

Antibiotic Exposure and Cardiovascular Disease Risk: A Nationwide Cohort Study
Park, Sun Jae , Kim, Minseo , Jeong, Seogsong , Choi, Seulggie , Kim, Hye Jun , Song, Jihun, Lee, Jaewon, Lee, Ji Won, Jeong, Jihui, Yu, Jiwon , Park, Young Jun , Kim, Hye Jun , Choi, Jiwon , Chang, Jooyoung , Oh, Yun Hwan , Ahn, Joseph C , Park, Sang Min , Lee, Ji‐Won , Chang, Jooyoung , Ahn, Joseph , Park, Sang Min

Journal of the American Heart Association | October 22, 2025 | Volume: 14 | Issue: 20 | Pages: No page available

10.1161/jaha.124.035888 | PMID 41120818 Get It

Background Antibiotic use may alter gut microbiota, which could be associated with various diseases, including cardiovascular disease (CVD). Accordingly, further epidemiological evidence is needed to clarify the potential risk of CVD associated with antibiotic exposure. We evaluated the association between long‐term antibiotic exposure and CVD risk in South Korea. Methods and Results This nationwide retrospective cohort study used data from the Korean National Health Insurance Service database. A total of 2 159 965 individuals aged 40 to 79 years who had no history of antibiotic prescriptions from 2004 to 2005 were included and followed through December 31, 2021. Antibiotic exposure was defined as the cumulative days of antibiotic prescriptions from 2006 to 2010. The primary end point was incident CVD with 2 or more days of hospitalization from 2011 to 2021. Adjusted hazard ratios (aHR) and 95% CIs for CVD according to antibiotic exposure were estimated using multivariable Cox proportional hazards models, adjusting for a range of covariates. Longer cumulative antibiotic prescription days were associated with an increased risk of CVD. The aHRs for CVD associated with 1 to 14, 15 to 90, 91 to 180, 181 to 364, and ≥365 days of antibiotic exposure were 0.98 (95% CI, 0.96–1.01), 1.01 (95% CI, 0.99–1.03), 1.05 (95% CI, 1.03–1.08), 1.06 (95% CI, 1.04–1.09), and 1.10 (95% CI, 1.07–1.13) compared with those with no antibiotic prescriptions. Conclusions In this large population‐based cohort study of Korean adults, long‐term antibiotic exposure may be associated with a higher risk of CVD. Further research is warranted to establish causality and elucidate the underlying mechanisms for this association.
Artificial Intelligence for Patient Education: A Primer, Not a Proxy
D’Souza, Ryan S. , Benzon, Honorio T., D'Souza, Ryan S , Benzon, Honorio T. , Nelson, Ariana M.

A&A Practice | October 21, 2025 | Volume: 19 | Issue: 10 | Pages: e02071

10.1213/xaa.0000000000002071 | PMID 41118602 Get It